What you should know:
1. If completed, the transaction will be Blackstone’s first in the Japanese market.
2. The transaction could close in the second quarter of 2019.
3. Ayumi’s flagship product Calonal is a leading acetaminophen drug used to treat chronic pain.
4. Ayumi also has a comprehensive synthetic and biosimilar product portfolio.
More articles on devices:
AAOS names Dr. Joseph Bosco III 1st vice president — 4 insights
5 insights into new AAHKS President Dr. Michael Bolognesi
HSS surgeon-in-chief emeritus makes $35k donation to high school
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
